Study of 9cUAB30 in Healthy Participants

Status Completed

Clinical Trial Summary

This research study is looking at 9cUAB30 in healthy participants. Studying samples of blood and urine from healthy participants may help doctors learn more about how 9cUAB30 is used by the body.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. To characterize the single-dose pharmacokinetics of 9cUAB30 in healthy volunteers.

SECONDARY OBJECTIVES:

I. To determine the toxicities of this drug in these participants. II. To correlate the pharmacokinetics with the toxicity of this drug in these participants.

OUTLINE:

Participants receive a single dose of oral 9cUAB30 on day 1. Blood and urine samples are collected at baseline, periodically on day 1, and then on day 8 for pharmacokinetic studies by high performance liquid chromatography.

After completion of treatment, participants are followed at days 8 and 30. ;

Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

No Evidence of Disease

Clinical Trial Details

NCT number	NCT00896974
Study type	Interventional
Source	National Cancer Institute (NCI)
Contact
Status	Completed
Phase	Phase 1
Start date	August 2008
Completion date	March 2010

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01230346` - Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer	N/A
Recruiting	`NCT03156309` - Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission	Phase 1
Active, not recruiting	`NCT02780401` - Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission	Phase 1
Completed	`NCT02099136` - Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers	Phase 2
Completed	`NCT03725449` - Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma	N/A
Completed	`NCT01497431` - Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants	Phase 1
Withdrawn	`NCT03120390` - Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors	N/A
Completed	`NCT02090933` - Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers	Phase 2
Terminated	`NCT02735512` - MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
Completed	`NCT01149096` - Collection of Bone Marrow From Donors Treated With or Without Filgrastim	Phase 3
Completed	`NCT02961790` - Oxybutynin Chloride in Managing Hot Flashes	Phase 3
Completed	`NCT02288416` - Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening	N/A
Completed	`NCT01698294` - Biomarkers in Post-Menopausal Women Receiving Flaxseed	N/A
Terminated	`NCT03284346` - Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors	N/A